Biotecnología
Biotecnología
Arranta Bio Expands RNA Process Development Capacity by 50%
10/03/2023 -
The expansion includes a state-of-the-art laboratory space with flexible, modular small scale and pilot scale equipment.
Evonik Opens New Facility for Pharmaceutical Lipids in Germany
10/03/2023 -
The types of lipids that can be produced at the facility will serve a broad range of RNA and gene therapies.
Korro Bio, Genevant to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
08/03/2023 -
Collaboration to combine Korro’s RNA editing technology and Genevant’s LNP technology.
GenScript ProBio, RVAC Medicines Enter GMP Plasmid DNA Manufacturing Pact
02/03/2023 -
Alliance will enable GenScript ProBio to accelerate its clinical manufacturing of mRNA-based COVID-19 vaccine, RVM-V001.
Polyplus Strengthens CGT Production Capabilities
02/03/2023 -
Announces GMP accreditation for DNA production at Xpress Biologics’ Belgian facility.
Touchlight Cleared by FDA for IND Utilizing Doggybone DNA
02/03/2023 -
Major landmark demonstrates the clinical adoption of Touchlight's proprietary technology across modalities.
Aji Bio-Pharma Develops Highly Functional Ancestral RNA Ligase
02/03/2023 -
New enzyme for double strand oligonucleotide formation with high productivity.
AcuraBio Expands cGMP Plasmid DNA, CDMO Services with Cytiva's Single-Use Purification Technology
15/02/2023 -
The new protocol features single-use purification technology which aims to deliver efficiency, high purity level outcome and sustainable process.
Element Biosciences, Bio-Rad Partner to Deliver Seamless Sequencing
15/02/2023 -
The SEQuoia Express Stranded RNA Library Prep Kit offers the additional benefit of an efficient 3-tube workflow for detection of long RNAs.
BioNTech SE Completes Plasmid DNA Manufacturing Facility in Marburg, Germany
03/02/2023 -
Will independently manufacture the majority of its own current regular demand for DNA plasmids in the new manufacturing facility.
Catalent Opens Manufacturing Facility for Cell Therapies
31/01/2023 -
Completes commercial-scale plasmid DNA manufacturing site in Gosselies, Belgium.
Forecyte Bio Opens CGT Production Facility in Maryland
18/01/2023 -
cGMP production suites in Frederick, MD are for plasmid DNA, viral vector and cell therapy production.
Nykode Therapeutics and Richter-Helm BioLogics Enter Manufacturing Partnership
04/01/2023 -
Richter-Helm to supply plasmid DNA for Nykode’s portfolio.
Lonza Joins GENEGUT Project to Develop Capsule Delivery Solution
26/10/2022 -
Four-year project aims to develop an innovative Crohn's disease treatment based on RNA and targeted delivery.
Yapan Bio Adds New Process Development Facility
19/10/2022 -
Expands capacity and capabilities in large molecule therapeutics to support development and manufacturing of RNA, DNA and gene therapy products.
TAAV’s Synthetic DNA Material Approved for Use in Clinical Trial
30/09/2022 -
dbDNA material to be used in upcoming approved Huntington's disease study in France.
Charles River, Cure AP-4 Enter Manufacturing Pact for Gene Therapy
13/09/2022 -
Charles River will provide High Quality (HQ) plasmid DNA for Cure AP-4’s Phase I/II gene therapy trials against AP-4 HSP.
GenScript Launches Expedited mRNA Service
22/08/2022 -
Provides an integrated workflow across gene synthesis, plasmid preparation and DNA linearization, and mRNA synthesis.
Mitochondrial DNA Mutations Linked to Heart Disease Risk
05/08/2022 -
UC San Diego and Salk Institute researchers report a surprising link between mitochondria, inflammation and gene mutations that may increase risk of atherosclerosis.
BioMedX Initiates New Oncology Research Project with Merck
02/08/2022 -
Aims to develop an atlas of extrachromosomal DNA in human cancer tissues and thereby trace back the mechanisms of ecDNA formation and function.
A Novel COVID-19 Vaccine Using Modified Bacterial DNA
22/07/2022 -
UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by...
